Dupont Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26,458
Closed -$6.47M 70
2026
Q1
$6.47M Buy
+26,458
New +$6.16M 0.74% 50
2024
Q2
Sell
-73,248
Closed -$11.6M 147
2024
Q1
$11.6M Sell
73,248
-4,564
-6% -$726K 0.96% 36
2023
Q4
$12.2M Sell
77,812
-2,024
-3% -$310K 1.07% 31
2023
Q3
$12.4M Buy
79,836
+50,149
+169% +$8.28M 1.09% 25
2023
Q2
$4.91M Buy
29,687
+3,569
+14% +$576K 0.24% 70
2023
Q1
$4.05M Sell
26,118
-1,977
-7% -$319K 0.19% 69
2022
Q4
$4.96M Sell
28,095
-15,498
-36% -$2.68M 0.24% 62
2022
Q3
$7.12M Sell
43,593
-31,211
-42% -$5.28M 0.42% 27
2022
Q2
$13.3M Sell
74,804
-1,822
-2% -$325K 0.62% 15
2022
Q1
$13.6M Sell
76,626
-8,729
-10% -$1.49M 0.55% 18
2021
Q4
$14.6M Sell
85,355
-35,046
-29% -$5.74M 0.52% 22
2021
Q3
$19.4M Sell
120,401
-35,863
-23% -$6.12M 0.61% 18
2021
Q2
$25.7M Sell
156,264
-8,481
-5% -$1.4M 0.61% 21
2021
Q1
$27.1M Sell
164,745
-29,905
-15% -$4.84M 0.65% 19
2020
Q4
$30.6M Sell
194,650
-41,314
-18% -$6.1M 0.65% 19
2020
Q3
$35.1M Sell
235,964
-32,867
-12% -$4.86M 0.77% 16
2020
Q2
$37.8M Buy
268,831
+22,642
+9% +$3.3M 0.83% 15
2020
Q1
$32.3M Buy
246,189
+32,182
+15% +$4.57M 0.77% 14
2019
Q4
$31.2M Buy
214,007
+16,156
+8% +$2.19M 0.7% 16
2019
Q3
$25.6M Sell
197,851
-38,839
-16% -$5.12M 0.59% 18
2019
Q2
$33M Sell
236,690
-45,823
-16% -$6.34M 0.75% 16
2019
Q1
$39.5M Sell
282,513
-101,635
-26% -$13.6M 0.9% 10
2018
Q4
$49.6M Buy
384,148
+114,015
+42% +$15.9M 1.21% 7
2018
Q3
$37.3M Buy
270,133
+40,744
+18% +$5.41M 0.82% 14
2018
Q2
$27.8M Sell
229,389
-29,815
-12% -$3.72M 0.66% 17
2018
Q1
$33.2M Sell
259,204
-2,700
-1% -$365K 0.8% 13
2017
Q4
$36.6M Sell
261,904
-3,391
-1% -$472K 0.84% 13
2017
Q3
$34.5M Sell
265,295
-64,827
-20% -$8.59M 0.78% 13
2017
Q2
$43.7M Buy
330,122
+53,912
+20% +$6.88M 0.97% 11
2017
Q1
$34.4M Buy
276,210
+117,688
+74% +$14.1M 0.76% 15
2016
Q4
$18.3M Sell
158,522
-19,340
-11% -$2.23M 0.41% 38
2016
Q3
$21M Sell
177,862
-31,176
-15% -$3.78M 0.47% 34
2016
Q2
$25.4M Sell
209,038
-26,816
-11% -$3.05M 0.56% 24
2016
Q1
$25.5M Sell
235,854
-12,617
-5% -$1.31M 0.58% 28
2015
Q4
$25.5M Buy
248,471
+32,043
+15% +$3.22M 0.62% 25
2015
Q3
$20.2M Buy
216,428
+23,768
+12% +$2.3M 0.51% 45
2015
Q2
$18.8M Hold
192,660
0.41% 62
2015
Q1
$19.4M Sell
192,660
-20,219
-9% -$2.06M 0.38% 67
2014
Q4
$22.3M Sell
212,879
-56,509
-21% -$5.96M 0.41% 63
2014
Q3
$28.7M Buy
269,388
+934
+0.3% +$96.9K 0.5% 40
2014
Q2
$28.1M Buy
268,454
+35,121
+15% +$3.55M 0.46% 37
2014
Q1
$22.9M Sell
233,333
-57,621
-20% -$5.34M 0.37% 47
2013
Q4
$26.6M Buy
290,954
+7,208
+3% +$664K 0.47% 39
2013
Q3
$24.6M Sell
283,746
-141,304
-33% -$12.7M 0.45% 46
2013
Q2
$36.5M Buy
+425,050
New +$36.1M 0.68% 24

Other funds holding JNJ

Dupont Capital Management's JNJ Position: Q2 2026 in Review

Dupont Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 26,458 shares — an estimated $6.47M sold.

Dupont Capital Management first reported a position in JNJ in Q2 2013 and held it in 45 quarters. The position peaked at $49.6M in Q4 2018. 4,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Dupont Capital Management reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Dupont Capital Management sold 26,458 Johnson & Johnson shares in Q2 2026, an estimated $6.47M.
  • Dupont Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 45 quarters.
  • Dupont Capital Management's Johnson & Johnson position peaked at $49.6M in Q4 2018.
  • 4,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.